US Onychomycosis Market 2017 Key Players - Valeant Pharmaceuticals, Pfizer, Inc., Novartis AG and Johnson & Johnson

"The Latest Research Report The US Onychomycosis Market (2017 Edition) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

The report entitled The US Onychomycosis Market (2017 Edition), provides analysis of the US onychomycosis market, with detailed analysis of market size and growth, market share and economic impact of the industry. The analysis includes the market by value, by volume and by segments. The report also includes the detailed analysis of the segments of the onychomycosis market, comprising of market by value, by volume and by average prices.

Valeant Pharmaceuticals, Pfizer, Inc., Novartis AG and Johnson & Johnson are some of the key players operating in the US onychomycosis market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/1221346

Company Coverage

Valeant Pahrmaceuticals
Pfizer, Inc.
Johnson and Johnson
Novartis AG

Executive Summary

Onychomycosis is a condition of fungal nail infection. Onychomycosis begins in the nail bed and progresses to the nail plate, causing the nail to become discolored, deformed, and even separated from the nail bed. Onychomycosis has a significant chance of reoccurrence. Of all the nail abnormalities in the world, around 50% are the case of onychomycosis. In most of the cases it occurs in the toenails. Onychomycosis is not a life threatening disease but, may persist or worsen if not treated. Symptoms of onychomycosis are changes in appearance of the nail, interference with standing, walking, and exercising, pain, discomfort, etc. The causative pathogens of onychomycosis include dermatophytes (most common), Candida, and nondermatophytic molds.

There are five types of Onychomycosis: Distal Subungual Onychomycosis, White superficial onychomycosis, Proximal subungual onychomycosis, Endonyx onychomycosis and Candidal onychomycosis. Two types of treatments are available of onychomycosis: Oral Treatment and Topical Treatment. Oral treatment includes: Terbinafine, Itraconazole, etc. and topical treatment includes Kerydin, Jublia, etc. Nonpharmacologic approaches are also there, which includes the following: Laser treatment, Photodynamic therapy, etc.

The US onychomycosis market (prescription drugs) has increased with a healthy growth rate over the years and is expected to increase further during the forecasted period. The US onychomycosis market is supported by various growth drivers, such as rising per capita healthcare expenditure, increasing diabetic patients, ageing population, introduction of new drugs, etc. Yet, the market faces certain challenges, such as, reimbursements, low awareness, side effects, etc.

Browse Complete Report with TOC @ https://www.marketresearchreports.biz/reports/1221346/the-us-onychomycosis-edition-market-research-reports/toc

Table Of Contents

1. Executive Summary

2. Introduction

2.1 Onychomycosis: An Overview

2.1.1 Signs and Symptoms
2.1.2 Causes of Onychomycosis

2.2 Types of Onychomycosis
2.3 Treatment for Onychomycosis

3. The US Market Analysis

3.1 The US Onychomycosis Market by Prevalence
3.1.1 The US Onychomycosis Market by Prevalence
3.1.2 The US Onychomycosis Market Prevalence by Segments

3.2 The US Nail Care Market: An Analysis
3.2.1 The US Nail Care Market by Value
3.2.2 The US Nail Care Market by Segments

3.3 The US Kerydin Drug Market: An Anlalysis
3.3.1 The US Kerydin Drug Market by Value
3.3.2 The US Kerydin Drug Market by Volume

3.4 The US Jublia Drug Market: An Analysis
3.4.1 The US Jublia Drug Market by Value
3.4.2 The US Jublia Drug Market by Volume

3.5 The US Generic Drugs Market: An Analysis
3.5.1 The US Generic Drugs Market by Value

3.6 Onychomycosis Market: New Drugs Overview
3.6.1 Global Skin Infection Market- Phase III Drugs (Onychomycosis) Pipeline Forecast
3.6.2 MOB-015
3.6.3 VT-1161

View Sample PDF @
https://www.marketresearchreports.biz/reports/1221346/the-us-onychomycosis-edition-market-research-reports.pdf

4. Competitive Landscape

4.1 Competition in Onychomycosis Prescription Market: An Overview
4.2 Financial Comparison of Major Players of the US Onychomycosis Market

5. Company Profiling

5.1 Valeant Pharmaceuticals
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategy

5.2 Pfizer
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategy

5.3 Johnson & Johnson
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategy

5.4 Novartis AG
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategy

Buy Now This Report From Here @ https://www.researchmoz.com/checkout?rep_id=1221346&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.